CD52 expression in mantle cell lymphoma.
Publication/Presentation Date
2-1-2002
Abstract
Mantle cell lymphoma is one of the most difficult to treat of all the non-Hodgkin's lymphomas. CAMPATH-1H, a humanized monoclonal antibody against the CD52 antigen, has been used with some success in other lymphoproliferative diseases, especially chronic lymphocytic leukemia. This report demonstrates that tumor samples from patients with mantle cell lymphoma express the CD52 antigen and suggests that CAMPATH-1H should be studied in patients with mantle cell lymphoma.
Volume
43
Issue
2
First Page
339
Last Page
342
ISSN
1042-8194
Published In/Presented At
Bass, A. J., Gong, J., Nelson, R., & Rizzieri, D. A. (2002). CD52 expression in mantle cell lymphoma. Leukemia & lymphoma, 43(2), 339–342. https://doi.org/10.1080/10428190290006125
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
11999566
Department(s)
Administration and Leadership
Document Type
Article